Table 2.
Section | Writer |
---|---|
Executive summary | Lead author(s) |
Public health relevance | Staff |
Requirements for diagnosis, treatment, and monitoring | Lead author(s) |
Overview of regimens | Lead author(s) |
Review of benefits and harms (including systematic reviews) | Lead author(s) and staff |
Recommendations | Lead author(s) |
Additions proposed for section 8.2 of EML | Lead author(s) |
Supplementary documents | |
Medicine prices from MSH price indicator guide (2014) | Staff |
Costing scenarios | Staff |
Regulatory information for recommended medicines | Staff |
Patent status for recommended medicines | Staff |
Granulocyte colony-stimulating factor | Lead author(s) and staff |
Abbreviations: EML, Model List of Essential Medicines; MSH, Management Sciences for Health.